Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Correction: Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).
[Therapeutic development for neuromyelitis optica].
Signs of myelin impairment in cerebrospinal fluid after osmotic opening of the blood-brain barrier in rats.
Patch-Based Segmentation with Spatial Consistency: Application to MS Lesions in Brain MRI.
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States.
Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke.
Syndrome of inappropriate antidiuretic hormone secretion in patients with aquaporin-4 antibody.
Obesity interacts with infectious mononucleosis in risk of multiple sclerosis.
Prediction of MS disability by multimodal evoked potentials: Investigation during relapse or in the relapse-free interval?
A comprehensive approach to the segmentation of multichannel three-dimensional MR brain images in multiple sclerosis.
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and susceptibility to vasculitis, rheumatoid arthritis, and multiple sclerosis: A meta-analysis.
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance.
An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy.
Gavin Giovannoni on why time matters in multiple sclerosis.
Role of phospholipase A(2)s and lipid mediators in secondary damage after spinal cord injury.
Psychological and Neurobehavioral Disorders in MSA Health-Oriented, Rehabilitative Perspective.
IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient.
Analyst insight: ECTRIMS 2012 congress highlights: Promising data offers hope for progressive MS
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
Walking execution is not affected by divided attention in patients with multiple sclerosis with no disability, but there is a motor planning impairment.
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
Molecular basis of axonal dysfunction and traffic impairments in CMT.

Pages